Stockscreener 앱 받기
35.06
0.11%
-0.04
시간 외 거래:
35.08
0.02
+0.06%
전일 마감가:
$35.10
열려 있는:
$35.01
하루 거래량:
147.44K
Relative Volume:
0.59
시가총액:
$322.13M
수익:
$103.14M
순이익/손실:
$-5.82M
주가수익비율:
-8.055
EPS:
-4.3526
순현금흐름:
$2.14M
1주 성능:
-0.03%
1개월 성능:
+1.12%
6개월 성능:
+114.57%
1년 성능:
+12.23%
1일 변동 폭
$34.97
$35.11
1주일 범위
$34.97
$35.34
52주 변동 폭
$16.05
$35.34
Sanara Medtech Inc Stock (SMTI) Company Profile
명칭
Sanara Medtech Inc
전화
817-529-2300
주소
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, RMD, ALC, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
35.06 | 322.13M | 103.14M | -5.82M | 2.14M | -4.3526 |
ISRG
Intuitive Surgical Inc
|
405.18 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.82 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
222.00 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.47 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.70 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Lake Street | Buy |
| 2025-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2024-12-23 | 개시 | H.C. Wainwright | Buy |
| 2022-05-20 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-30 | 개시 | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc 주식(SMTI)의 최신 뉴스
Sanara MedTech stock reports 9 percent revenue growth - ad-hoc-news.de
Sanara MedTech (SMTI) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Precision Trading with Sanara Medtech Inc. (SMTI) Risk Zones - Stock Traders Daily
SMTI - Finviz
Sanara MedTech stock holds near its 52-week high - ad-hoc-news.de
Sanara MedTech CEO Yon Seth D Forfeits 3,661 Shares at $35.11 Each - Kalkine Media
Sanara Medtech Inc (SMTI) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc.SMTI - Business Wire
MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - The Globe and Mail
[DEFM14A] Sanara MedTech Inc. Merger Proxy Statement - stocktitan.net
Why (SMTI) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SMTI Q2 2026 Earnings: Wider-Than-Expected Loss Highlights Cost PressurePost-Announcement Reaction - dars.gov.et
Sanara MedTech (SMTI) Holds Steady at $34.57 as Traders Eye Resistance at $36.30ATR Trailing Stop - dars.gov.et
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanar - The National Law Review
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders - The Daily Tribune News
SMTI | Sanara MedTech Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - Eastern Progress
Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan
Sanara MedTech Inc. (NASDAQ:SMTI) Short Interest Update - MarketBeat
Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI - MarketBeat
SMTI Q1 2026 Earnings: Positive EPS Surprise Overcomes Expected LossOne-Time Gain Impact - vinanet.vn
Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny - Sahm
(SMTI) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) - The Manila Times
Sanara Medtech earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada
Sanara Medtech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate - scanx.trade
Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary - TradingView
Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss - Stock Titan
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com Nigeria
Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media
Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9% - Quiver Quantitative
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech Q2 revenue rises on soft-tissue product growth - TradingView
Sanara MedTech (SMTI) grows revenue, posts Q2 loss amid pending MIMEDX deal - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Sanara Medtech Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTec - The National Law Review
Sanara MedTech (SMTI) Expected to Post Earnings on Wednesday - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc - The National Law Review
Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
How (SMTI) Movements Inform Risk Allocation Models - Stock Traders Daily
Sanara MedTech (SMTI) Holds Near $33.86 as Support Levels Come into FocusRSI Oversold Picks - siam.in
Sanara Medtech Inc (SMTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
0.51%
자본화:
|
볼륨(24시간):